Literature DB >> 16103174

Role of plasminogen in propagation of scrapie.

Mario Salmona1, Raffaella Capobianco, Laura Colombo, Ada De Luigi, Giacomina Rossi, Michela Mangieri, Giorgio Giaccone, Elena Quaglio, Roberto Chiesa, Maria Benedetta Donati, Fabrizio Tagliavini, Gianluigi Forloni.   

Abstract

To investigate whether plasminogen may feature in scrapie infection, we inoculated plasminogen-deficient (Plg(-/-)), heterozygous plasminogen-deficient (Plg(+/-)), and wild-type (Plg(+/+)) mice by the intracerebral or intraperitoneal (i.p.) route with the RML scrapie strain and monitored the onset of neurological signs of disease, survival time, brain, and accumulation of scrapie disease-associated forms of the prion protein (PrP(Sc)). Only after i.p. inoculation, a slight, although significant, difference in survival (P < 0.05) between Plg(-/-) and Plg(+/+) mice was observed. Neuropathological examination and Western blot analysis were carried out when the first signs of disease appeared in Plg(+/+) animals (175 days after i.p. inoculation) and when mice reached the terminal stage of illness. At the onset of symptoms, PrP(Sc) accumulation was higher in the brain and spleen of Plg(+/+) and Plg(+/-) mice than in those of Plg(-/-) mice, and these differences were paralleled by differences in the severity of spongiform changes and astrogliosis in the cerebral cortex and subcortical gray structures. Immunohistochemical analysis of the spleens before inoculation did not show any impairment of the immune system affecting follicular dendritic or lymphoid cells in Plg(-/-) mice. Once the disease progressed and mice began to die of infection, differences were no longer apparent in either brains or spleens. In conclusion, our data indicate that plasminogen has no major effect on the survival of scrapie agent-infected mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103174      PMCID: PMC1193643          DOI: 10.1128/JVI.79.17.11225-11230.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Creutzfeldt-Jakob disease: Carnoy's fixative improves the immunohistochemistry of the proteinase K-resistant prion protein.

Authors:  G Giaccone; B Canciani; G Puoti; G Rossi; D Goffredo; S Iussich; P Fociani; F Tagliavini; O Bugiani
Journal:  Brain Pathol       Date:  2000-01       Impact factor: 6.508

2.  Plasminogen binds to disease-associated prion protein of multiple species.

Authors:  M Maissen; C Roeckl; M Glatzel; W Goldmann; A Aguzzi
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

3.  Cooperative binding of dominant-negative prion protein to kringle domains.

Authors:  Chongsuk Ryou; Stanley B Prusiner; Giuseppe Legname
Journal:  J Mol Biol       Date:  2003-05-30       Impact factor: 5.469

4.  Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.

Authors:  F Tagliavini; G Forloni; L Colombo; G Rossi; L Girola; B Canciani; N Angeretti; L Giampaolo; E Peressini; T Awan; L De Gioia; E Ragg; O Bugiani; M Salmona
Journal:  J Mol Biol       Date:  2000-07-28       Impact factor: 5.469

5.  Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner.

Authors:  Vincent Ellis; Maki Daniels; Rashmi Misra; David R Brown
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

Review 6.  Molecular biology of prion diseases.

Authors:  S B Prusiner
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

7.  Cell-free formation of protease-resistant prion protein.

Authors:  D A Kocisko; J H Come; S A Priola; B Chesebro; G J Raymond; P T Lansbury; B Caughey
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

8.  Experimental transmission of scrapie to voles and Chinese hamsters.

Authors:  R L Chandler
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

9.  Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie.

Authors:  N A Mabbott; M E Bruce; M Botto; M J Walport; M B Pepys
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

10.  Tetracyclines affect prion infectivity.

Authors:  Gianluigi Forloni; Selina Iussich; Tazeen Awan; Laura Colombo; Nadia Angeretti; Laura Girola; Ilaria Bertani; Giorgio Poli; Maria Caramelli; Maria Grazia Bruzzone; Laura Farina; Lucia Limido; Giacomina Rossi; Giorgio Giaccone; James W Ironside; Orso Bugiani; Mario Salmona; Fabrizio Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

View more
  10 in total

1.  Plasminogen: A cellular protein cofactor for PrPSc propagation.

Authors:  Charles E Mays; Chongsuk Ryou
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

2.  Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients.

Authors:  Cao Chen; Di Xiao; Wei Zhou; Qi Shi; Hui-Fang Zhang; Jin Zhang; Chan Tian; Jian-Zhong Zhang; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-08-04       Impact factor: 5.590

3.  Therapeutic activity of inhibition of the soluble epoxide hydrolase in a mouse model of scrapie.

Authors:  Giorgio Poli; Erica Corda; Piera Anna Martino; Paola Dall'ara; Silvio R Bareggi; Giampietro Bondiolotti; Barbara Iulini; Maria Mazza; Cristina Casalone; Sung Hee Hwang; Bruce D Hammock; Bora Inceoglu
Journal:  Life Sci       Date:  2013-05-05       Impact factor: 5.037

4.  Human prions and plasma lipoproteins.

Authors:  Jiri G Safar; Holger Wille; Michael D Geschwind; Camille Deering; Diane Latawiec; Ana Serban; David J King; Giuseppe Legname; Karl H Weisgraber; Robert W Mahley; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-18       Impact factor: 11.205

5.  Reduction of canine plasminogen leads to an expanded molecule which precipitates.

Authors:  Jack A Kornblatt
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

6.  Canine plasminogen: spectral responses to changes in 6-aminohexanoate and temperature.

Authors:  Jack A Kornblatt; Tanya A Barretto; Ketevan Chigogidze; Bahati Chirwa
Journal:  Anal Chem Insights       Date:  2007-03-22

7.  Metal Ions Bound to Prion Protein Affect its Interaction with Plasminogen Activation System.

Authors:  Maryam Borumand; Vincent Ellis
Journal:  Protein J       Date:  2022-01-17       Impact factor: 2.371

8.  Endoproteolysis of cellular prion protein by plasmin hinders propagation of prions.

Authors:  Charles E Mays; Trang H T Trinh; Glenn Telling; Hae-Eun Kang; Chongsuk Ryou
Journal:  Front Mol Neurosci       Date:  2022-09-02       Impact factor: 6.261

9.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

10.  In vitro screen of prion disease susceptibility genes using the scrapie cell assay.

Authors:  Craig A Brown; Christian Schmidt; Mark Poulter; Holger Hummerich; Peter-C Klöhn; Parmjit Jat; Simon Mead; John Collinge; Sarah E Lloyd
Journal:  Hum Mol Genet       Date:  2014-05-15       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.